Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Two local biotechs go public, raising $540 million total

Por: The Boston Globe Business September 13, 2024

thumbnail

Two Boston-area biotechnology companies held initial public offerings on Friday, bringing in $540 million total to fuel their growth and doubling the number of Massachusetts biotech companies to go public in 2024.Boston-based Bicara Therapeutics Inc., a biopharmaceuticals company, brought in $315 million, selling 17.5 million shares at $18 per share, according to Bloomberg data.Waltham-based Zenas BioPharma, which develops immunology-based... + full article



Similar News

Waltham startup expected to complete first local biotech IPO of the year

The Boston Globe USA Business July 11, 2023

thumbnailAfter a long dry spell in initial public offerings by biotech firms, a startup spun out of a Waltham company has filed to be listed on the Nasdaq and hopes to raise $250 million.Apogee Therapeutics is the first biotech in Massachusetts seeking to go public this year, according... + más

What Are the Duties of A Trustee? | Forbes

Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek


15 Biotech Stocks Wall Street Analysts Say Are Too Cheap

MarketWatch USA Business June 21, 2023

thumbnailThe XBI is still down roughly 50% from its high in February 2021, but things in the sector are looking better than they have in a while. In an effort to find opportunities, Barron’s screened the XBI and another biotech ETF, the (IBB), for the stocks with a market value of more... + más

US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business

Daydream Believers: Read This Before You Invest In AI | Forbes


Many Biotechs Have Net Assets That Top Their Market Values

MarketWatch USA Business June 04, 2023

thumbnailIt’s not alone. The collapse of biotech valuations since early 2021 has left a substantial number of biotechs in that position, which is known as having a negative enterprise value. It’s a stark sign of how grim things have gotten for small biotechs, and how far the sector... + más

Stocks remain overpriced, even vs. the dot-com bubble. But you can still find good picks in these 2 sectors. | MarketWatch

Stocks remain overpriced, even vs. the dot-com bubble. But you can still find good picks in these 2 sectors. | MarketWatch


Despite biotech downturn, new Boston VC firm raises $350 million to fund startups

The Boston Globe USA Business April 04, 2023

thumbnailThe past couple of years have been brutal for Massachusetts biotechs, with share prices of publicly traded companies plunging, the appetite for initial public offerings dwindling, firms laying off workers, and demand for real estate shrinking.That didn’t stop a recently... + más

Fewest Mass. startups since 2016 got VC funding in the first quarter | The Boston Globe

US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business


Garmin Edge 540 And Edge 840 Cycle Computers Leak Online

Forbes USA Tech March 27, 2023

thumbnailGarmin Edge 840 SolarGarmin US retailer Adorama has posted pictures and prices for the Garmin Edge 540 and 840 cycle computers ahead of their official announcement, as noted by users on the forum. If these details aren’t altered ahead of Garmin’s official announcement, you... + más

Garmin introduces its first smart blood pressure monitor | The Verge

Tech company Garmin plans 50 hires, build-out at its Yarmouth site | Portland Press Herald


Stocks remain overpriced, even vs. the dot-com bubble. But you can still find good picks in these 2 sectors.

MarketWatch USA Business December 22, 2022

thumbnailRead:  For all the grinding lower of this market, it’s still not that cheap, as Michael O’Rourke, chief strategist at JonesTrading, reminds us. He notes that the S&P 500 market cap to GDP has shrunk to 129% from 180% almost a year ago, thanks to the tech-led pullback.... + más

Forget The New MacBook Pro, Apple Has Something Better | Forbes

NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN


Stocks remain overpriced, even vs. the dot-com bubble. But you can still find good picks in these 2 sectors.

MarketWatch USA Politics December 22, 2022

thumbnailRead:  For all the grinding lower of this market, it’s still not that cheap, as Michael O’Rourke, chief strategist at JonesTrading, reminds us. He notes that the S&P 500 market cap to GDP has shrunk to 129% from 180% almost a year ago, thanks to the tech-led pullback.... + más

Forget The New MacBook Pro, Apple Has Something Better | Forbes

NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN



About iurex | Privacy Policy | Disclaimer |